178 related articles for article (PubMed ID: 23473653)
1. The effect of providing patient-specific electronically monitored antipsychotic medication adherence results on the treatment planning of prescribers of outpatients with schizophrenia.
Nakonezny PA; Byerly MJ; Pradhan A
Psychiatry Res; 2013 Jun; 208(1):9-14. PubMed ID: 23473653
[TBL] [Abstract][Full Text] [Related]
2. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder.
Byerly MJ; Nakonezny PA; Rush AJ
Schizophr Res; 2008 Mar; 100(1-3):60-9. PubMed ID: 18255269
[TBL] [Abstract][Full Text] [Related]
3. Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia.
Byerly MJ; Thompson A; Carmody T; Bugno R; Erwin T; Kashner M; Rush AJ
Psychiatr Serv; 2007 Jun; 58(6):844-7. PubMed ID: 17535946
[TBL] [Abstract][Full Text] [Related]
4. Symptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophrenia.
Yang J; Ko YH; Paik JW; Lee MS; Han C; Joe SH; Jung IK; Jung HG; Kim SH
Schizophr Res; 2012 Feb; 134(2-3):226-31. PubMed ID: 22133906
[TBL] [Abstract][Full Text] [Related]
5. Electronically monitored adherence in outpatients with schizophrenia or schizoaffective disorder: a comparison of first- vs. second-generation antipsychotics.
Nakonezny PA; Byerly MJ
Schizophr Res; 2006 Feb; 82(1):107-14. PubMed ID: 16376522
[TBL] [Abstract][Full Text] [Related]
6. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
[TBL] [Abstract][Full Text] [Related]
7. Brief interventions for improving adherence in schizophrenia: A pilot study using electronic medication event monitoring.
Tessier A; Dupuy M; Baylé FJ; Herse C; Lange AC; Vrijens B; Schweitzer P; Swendsen J; Misdrahi D
Psychiatry Res; 2020 Mar; 285():112780. PubMed ID: 31954541
[TBL] [Abstract][Full Text] [Related]
8. Electronic monitoring of antipsychotic medication adherence in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of its reliability and predictive validity.
Nakonezny PA; Byerly MJ; Rush AJ
Psychiatry Res; 2008 Jan; 157(1-3):259-63. PubMed ID: 17935793
[TBL] [Abstract][Full Text] [Related]
9. A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder.
Byerly MJ; Fisher R; Carmody T; Rush AJ
J Clin Psychiatry; 2005 Aug; 66(8):997-1001. PubMed ID: 16086614
[TBL] [Abstract][Full Text] [Related]
10. Adherence to treatment and therapeutic strategies in schizophrenic patients: the ADHERE study.
Gutiérrez-Casares JR; Cañas F; Rodríguez-Morales A; Hidalgo-Borrajo R; Alonso-Escolano D
CNS Spectr; 2010 May; 15(5):327-37. PubMed ID: 20448523
[TBL] [Abstract][Full Text] [Related]
11. Adherence to antipsychotic and nonpsychiatric medications in middle-aged and older patients with psychotic disorders.
Dolder CR; Lacro JP; Jeste DV
Psychosom Med; 2003; 65(1):156-62. PubMed ID: 12554828
[TBL] [Abstract][Full Text] [Related]
12. Strategies for improving treatment adherence in schizophrenia and schizoaffective disorder.
Goff DC; Hill M; Freudenreich O
J Clin Psychiatry; 2010; 71 Suppl 2():20-6. PubMed ID: 21190649
[TBL] [Abstract][Full Text] [Related]
13. Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study.
Baloush-Kleinman V; Levine SZ; Roe D; Shnitt D; Weizman A; Poyurovsky M
Schizophr Res; 2011 Aug; 130(1-3):176-81. PubMed ID: 21636254
[TBL] [Abstract][Full Text] [Related]
14. Medication management ability assessment: results from a performance-based measure in older outpatients with schizophrenia.
Patterson TL; Lacro J; McKibbin CL; Moscona S; Hughs T; Jeste DV
J Clin Psychopharmacol; 2002 Feb; 22(1):11-9. PubMed ID: 11799337
[TBL] [Abstract][Full Text] [Related]
15. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
[TBL] [Abstract][Full Text] [Related]
16. Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia.
Achtyes E; Simmons A; Skabeev A; Levy N; Jiang Y; Marcy P; Weiden PJ
BMC Psychiatry; 2018 Sep; 18(1):292. PubMed ID: 30223804
[TBL] [Abstract][Full Text] [Related]
17. Predictors of medication non-adherence in Bulgarian outpatients with schizophrenia.
Vassileva I; Milanova V; Asan T
Community Ment Health J; 2014 Oct; 50(7):854-61. PubMed ID: 24452824
[TBL] [Abstract][Full Text] [Related]
18. Community adherence to schizophrenia treatment and safety monitoring guidelines.
Keller WR; Fischer BA; McMahon R; Meyer W; Blake M; Buchanan RW
J Nerv Ment Dis; 2014 Jan; 202(1):6-12. PubMed ID: 24375205
[TBL] [Abstract][Full Text] [Related]
19. Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia.
Diaz E; Levine HB; Sullivan MC; Sernyak MJ; Hawkins KA; Cramer JA; Woods SW
J Psychiatry Neurosci; 2001 Sep; 26(4):325-9. PubMed ID: 11590972
[TBL] [Abstract][Full Text] [Related]
20. Descriptions and Correlates of Medication Adherence, Attitudes, and Self-Efficacy in Outpatients With Schizophrenia Spectrum Disorders (SSDs).
Beebe LH; Smith K; Phillips C
Arch Psychiatr Nurs; 2016 Jun; 30(3):400-5. PubMed ID: 27256948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
